The Human Medicines Regulations 2012: what changed
1,250 changes of wording, as read on 19 Nov 2026.
The latest 200 of 1,250.
12
- amended
Human Medicines Regulations 2012, 3 · Scope of these Regulations: special provisions
- amended
Human Medicines Regulations 2012, 3a · Preparation and assembly of medicinal products used for vaccination against an infectious disease or in the reformulation of such products
- amended
Human Medicines Regulations 2012, 8 · General interpretation
- amended
Human Medicines Regulations 2012, 19 · Exemptions from requirement for wholesale dealer's licence
- amended
Human Medicines Regulations 2012, 213 · Interpretation
- amended
Human Medicines Regulations 2012, 233 · Exemption for supply etc under a PGD by person conducting a retail pharmacy business
- new
Human Medicines Regulations 2012, 235a · Exemption for supply or administration of certain medicines used for vaccination
- amended
Human Medicines Regulations 2012, 247a · Protocols relating to coronavirus and influenza vaccinations and immunisations
- amended
Human Medicines Regulations 2012, 250 · Exceptions to regulation 249
- amended
- amended
- amended
13
- amended
Human Medicines Regulations 2012, 62 · Classification of UK marketing authorisation or parallel import licence
- amended
Human Medicines Regulations 2012, 106 · Classification of certificate of registration
- amended
Human Medicines Regulations 2012, 131 · Classification of traditional herbal registration
- amended
Human Medicines Regulations 2012, 217b · Original pack dispensing
- amended
Human Medicines Regulations 2012, 217ba · Original pack dispensing: Northern Ireland
- amended
Human Medicines Regulations 2012, 217c · Original pack dispensing: medicinal products containing a relevant substance
- amended
Human Medicines Regulations 2012, 217ca · Original pack dispensing: medicinal products containing a relevant substance: Northern Ireland
- amended
Human Medicines Regulations 2012, 220 · Sale or supply of medicinal products not subject to general sale
- new
Human Medicines Regulations 2012, 220b · Sale or supply of items dispensed by a pharmacist who is absent or treated as absent
- amended
Human Medicines Regulations 2012, 248 · Exemption for certain collection and delivery arrangements
- amended
Human Medicines Regulations 2012, 250 · Exceptions to regulation 249
- amended
Human Medicines Regulations 2012, 255 · Offences relating to dealings with medicinal products
- amended
11
- amended
Human Medicines Regulations 2012, 3 · Scope of these Regulations: special provisions
- amended
Human Medicines Regulations 2012, 8 · General interpretation
- amended
Human Medicines Regulations 2012, 18 · Wholesale dealing in medicinal products
- amended
Human Medicines Regulations 2012, 220 · Sale or supply of medicinal products not subject to general sale
- amended
Human Medicines Regulations 2012, 221 · Sale or supply of medicinal products subject to general sale
- new
Human Medicines Regulations 2012, 222a · Assembly or part-assembly as part of “hub and spoke” dispensing arrangements between different businesses
- new
Human Medicines Regulations 2012, 222b · Hub and spoke arrangements: sharing of data between different businesses
- amended
Human Medicines Regulations 2012, 274 · Exemptions from regulation 273
- new
- new
- new
84
- amended
Human Medicines Regulations 2012, 17 · Manufacturing of medicinal products
- new
Human Medicines Regulations 2012, 17a · Manufacturing of MM medicinal products
- new
Human Medicines Regulations 2012, 17b · Manufacturing of POC medicinal products
- amended
Human Medicines Regulations 2012, 20 · Mixing of medicines
- amended
Human Medicines Regulations 2012, 22 · Factors relevant to determination of application for manufacturer's or wholesale dealer's licence
- amended
Human Medicines Regulations 2012, 26 · General power to suspend, revoke or vary licences
- new
Human Medicines Regulations 2012, 27a · Effect of suspension or variation relating to modular unit or POC site
- amended
Human Medicines Regulations 2012, 29 · Variation of licence on the application of the holder
- new
Human Medicines Regulations 2012, 29a · Variation of MM master file
- new
Human Medicines Regulations 2012, 29b · Variation of POC master file
- amended
Human Medicines Regulations 2012, 37 · Manufacturing and assembly
- new
Human Medicines Regulations 2012, 37a · Manufacturing and assembly of MM medicinal products: additional requirements
- new
Human Medicines Regulations 2012, 37b · Manufacturing and assembly of POC medicinal products: additional requirements
- amended
Human Medicines Regulations 2012, 39 · Further requirements for manufacturer's licence
- amended
Human Medicines Regulations 2012, 50 · Accompanying material
- new
Human Medicines Regulations 2012, 50k · Applications relating to POC medicinal products
- new
Human Medicines Regulations 2012, 74a · Obligation to provide information relating to methods of manufacture and control: MM medicinal products
- new
Human Medicines Regulations 2012, 74b · Obligation to provide information relating to methods of manufacture and control: POC medicinal products
- amended
Human Medicines Regulations 2012, 167 · Supply to fulfil special patient needs
- amended
Human Medicines Regulations 2012, 167g · EAMS medicinal products: pharmacovigilance
- amended
Human Medicines Regulations 2012, 169 · Mixing of general sale medicinal products
- amended
Human Medicines Regulations 2012, 170 · Record-keeping requirements
- new
Human Medicines Regulations 2012, 170a · MM medicinal products: pharmacovigilance requirements
- new
Human Medicines Regulations 2012, 170b · POC medicinal products: pharmacovigilance requirements
- amended
Human Medicines Regulations 2012, 171 · Exempt advanced therapy medicinal products
- amended
Human Medicines Regulations 2012, 175 · Offences relating to exceptions
- amended
Human Medicines Regulations 2012, 178 · General obligations of the licensing authority
- amended
Human Medicines Regulations 2012, 188 · Reporting obligations on holders
- amended
Human Medicines Regulations 2012, 202a · Licensing authority power in relation to medicinal products subject to additional monitoring
- amended
Human Medicines Regulations 2012, 257 · Packaging requirements: general
- amended
Human Medicines Regulations 2012, 257c · Packaging requirements: advanced therapy medicinal products
- new
Human Medicines Regulations 2012, 257ca · Packaging requirements: POC medicinal products
- amended
Human Medicines Regulations 2012, 258 · Packaging requirements: specific provisions
- amended
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- amended
- amended
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
- new
80
- amended
Human Medicines Regulations 2012, 2a · Definition of advanced therapy medicinal product etc.
- amended
Human Medicines Regulations 2012, 4 · Special provisions for pharmacies etc
- amended
Human Medicines Regulations 2012, 5 · Classification of medicinal products
- amended
Human Medicines Regulations 2012, b17 · Regulations on good manufacturing practice
- amended
Human Medicines Regulations 2012, c17 · Guidelines on good manufacturing practice and good distribution practice
- amended
Human Medicines Regulations 2012, 17 · Manufacturing of medicinal products
- amended
Human Medicines Regulations 2012, 18 · Wholesale dealing in medicinal products
- amended
Human Medicines Regulations 2012, 19 · Exemptions from requirement for wholesale dealer's licence
- amended
Human Medicines Regulations 2012, 31 · Certification of manufacturer's licence
- amended
Human Medicines Regulations 2012, 36 · Conditions for manufacturer's licence
- amended
Human Medicines Regulations 2012, 37 · Manufacturing and assembly
- amended
Human Medicines Regulations 2012, 39 · Further requirements for manufacturer's licence
- amended
Human Medicines Regulations 2012, 42 · Conditions for wholesale dealer's licence
- amended
Human Medicines Regulations 2012, 43 · Obligations of licence holder
- amended
Human Medicines Regulations 2012, 43a · Requirement for wholesale dealers to decommission the unique identifier
- amended
Human Medicines Regulations 2012, 44 · Requirement for wholesale dealers to deal only with specified persons
- amended
Human Medicines Regulations 2012, 45a · Brokering in medicinal products
- amended
Human Medicines Regulations 2012, 45e · Criteria of broker’s registration
- amended
Human Medicines Regulations 2012, 45f · Provision of information
- amended
Human Medicines Regulations 2012, 46 · Requirement for authorisation
- amended
Human Medicines Regulations 2012, 48 · Application of this Part
- amended
Human Medicines Regulations 2012, 49 · Application for grant of UK marketing authorisation or parallel import licence
- amended
Human Medicines Regulations 2012, 50 · Accompanying material
- amended
Human Medicines Regulations 2012, 50a · Requirement for certain applications to include results of paediatric investigation plan
- amended
Human Medicines Regulations 2012, 50e · Application for paediatric use marketing authorisation
- amended
Human Medicines Regulations 2012, 50f · Other applications including paediatric indications
- amended
Human Medicines Regulations 2012, 50g · Applications relating to orphan medicinal products
- amended
Human Medicines Regulations 2012, 50h · Applications relating to advanced therapy medicinal products
- amended
Human Medicines Regulations 2012, 50i · Applications relating to conditional marketing authorisations …
- amended
Human Medicines Regulations 2012, 51 · Application for UKMA(NI) relating to generic medicinal products
- amended
Human Medicines Regulations 2012, 51a · Application for UKMA(GB) relating to generic medicinal products
- amended
Human Medicines Regulations 2012, 51b · Application for UKMA(UK) relating to generic medicinal products
- amended
Human Medicines Regulations 2012, 52 · Application for UKMA(NI) relating to certain medicinal products that do not qualify as generic etc
- amended
Human Medicines Regulations 2012, 52a · Application for UKMA(GB) relating to certain medicinal products that do not qualify as generic etc
- amended
Human Medicines Regulations 2012, 52b · Application for UKMA(UK) relating to certain medicinal products that do not qualify as generic etc.
- amended
Human Medicines Regulations 2012, 53 · Application for UKMA(NI) relating to similar biological medicinal products
- amended
Human Medicines Regulations 2012, 53a · Application for UKMA(GB) relating to similar biological medicinal products
- amended
Human Medicines Regulations 2012, 53b · Application for UKMA(UK) relating to similar biological medicinal products
- amended
Human Medicines Regulations 2012, 55 · Applications relating to new combinations of active substances
- amended
Human Medicines Regulations 2012, 58 · Consideration of application
- amended
Human Medicines Regulations 2012, 58a · Paediatric rewards
- amended
Human Medicines Regulations 2012, 58f · Consideration of applications relating to conditional marketing authorisations
- amended
Human Medicines Regulations 2012, 59 · Conditions of UK marketing authorisation or parallel import licence: general
- amended
Human Medicines Regulations 2012, 60 · Conditions of UK marketing authorisation or parallel import licence: exceptional circumstances
- amended
Human Medicines Regulations 2012, 60a · Condition as to the submitting of samples and other information to the appropriate authority
- amended
Human Medicines Regulations 2012, 60b · Submitting of samples and other information: EU marketing authorisations
- amended
Human Medicines Regulations 2012, 61 · Conditions of UK marketing authorisation: new obligations post-authorisation
- amended
Human Medicines Regulations 2012, 64 · Duties of licensing authority in connection with determination
- amended
Human Medicines Regulations 2012, 65c · Variation of a UKMA(GB) or a UKMA(UK)(Category 1)
- amended
Human Medicines Regulations 2012, 66 · Application for renewal of authorisation
- amended
Human Medicines Regulations 2012, 67 · Failure to place on the market etc
- amended
Human Medicines Regulations 2012, 68 · Revocation, variation and suspension of UK marketing authorisation or parallel import licence
- amended
Human Medicines Regulations 2012, 71 · Withdrawal of medicinal product from the market
- amended
Human Medicines Regulations 2012, 72 · Sale etc of suspended medicinal product
- amended
Human Medicines Regulations 2012, 73 · Obligation to notify placing on the market etc
- amended
Human Medicines Regulations 2012, 76 · Obligation in relation to product information
- amended
Human Medicines Regulations 2012, 78b · Post authorisation requirements in relation to UKMA(UK)(Category 1) for advanced therapy medicinal products
- amended
Human Medicines Regulations 2012, 79 · Failure to provide information on marketing authorisations to EMA
- amended
Human Medicines Regulations 2012, 80 · Urgent safety restrictions
- amended
Human Medicines Regulations 2012, a81 · Application of regulations 89 to 94
- amended
Human Medicines Regulations 2012, 81 · Obligation to update information supplied in connection with EU application
- amended
Human Medicines Regulations 2012, 82 · EU marketing authorisations: failure to notify placing on market etc
- amended
Human Medicines Regulations 2012, 83 · EU marketing authorisations: failure to take account of technical and scientific progress
- amended
Human Medicines Regulations 2012, 84 · EU marketing authorisations: failure to provide information as to safety etc
- amended
Human Medicines Regulations 2012, 85 · EU marketing authorisations: failure to update product information
- amended
Human Medicines Regulations 2012, 86 · EU marketing authorisations: breach of pharmacovigilance condition etc
- amended
Human Medicines Regulations 2012, 87 · Offences in connection with risk management systems and traceability systems
- amended
Human Medicines Regulations 2012, 88 · Offence concerning data for advanced therapy medicinal products
- amended
Human Medicines Regulations 2012, 94a · Offences relating to Commission Regulation 2016/161
- amended
Human Medicines Regulations 2012, 95 · Offences in connection with application
- amended
Human Medicines Regulations 2012, 101 · Defences
- amended
Human Medicines Regulations 2012, 159 · Provisional determination
- amended
Human Medicines Regulations 2012, 164 · Effect of final determination
- amended
Human Medicines Regulations 2012, 169 · Mixing of general sale medicinal products
- amended
Human Medicines Regulations 2012, 171 · Exempt advanced therapy medicinal products
- amended
Human Medicines Regulations 2012, 173 · Exemption for certain radiopharmaceuticals
- amended
Human Medicines Regulations 2012, 177 · Application of this Part and interpretation
- amended
Human Medicines Regulations 2012, 180 · Obligation on licensing authority to audit pharmacovigilance system
- amended
Human Medicines Regulations 2012, 181 · Delegation of obligations under this Part
- amended
Human Medicines Regulations 2012, 184 · Obligation on holder to audit pharmacovigilance system